Table 1.

Stakeholder groups in the study

Stakeholder fields	Expected quantity	Recruitment methods
CM/integrated Chinese and Western medicine	15–20	(1) The identification of stakeholders begins with a preliminary list of experts and patients
Clinical pharmacy	4–6	(2) The preliminary list will be augmented with authors of studies included in the systematic review
Clinical epidemiology	4–6
		(3) Stakeholders will recommend whomever else they think should be included as a relevant stakeholder
Statistics	4–6
		(4) An email will be sent to the identified panelists who registered with informed consents to explain this study and the importance of the Delphi survey
Patients	15–20
Editors of important relevant journals	4–6	Editors from important relevant journals on hyperlipidemia will be invited via email